Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants - Concepedia

Concepedia

Publication | Closed Access

Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants

51

Citations

18

References

2006

Year

Daniele Barbaro, Giuseppe Boni, Giuseppe Meucci, U Simi, Paola Lapi, Paola Orsini, Cristina Pasquini, Anna Turco, Giuliano Mariani

Nuclear Medicine Communications

Abstract

Our data confirm that, when the interference of iodine is minimized, rhTSH is highly effective for the treatment of post-surgical thyroid remnants using a low dose of (131)I.

References

	Year	Citations
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Ernest L. Mazzaferri, Sissy Jhiang The American Journal of Medicine Medical TherapySurgical OncologyLong-term ImpactMedicineThyroid Disease	1994	2.6K
Natural History, Treatment, and Course of Papillary Thyroid Carcinoma* Leslie J. DeGroot, Edwin L. Kaplan, Maureen McCormick, The Journal of Clinical Endocrinology & Metabolism	1990	1.1K
Prognosis and Treatment of Brain Metastases in Thyroid Carcinoma Alice C. Chiu, Ebrahim S. Delpassand, Steven I. Sherman The Journal of Clinical Endocrinology & Metabolism Surgical OncologyBrain MetastasesPathologyNeuro-oncologyOncology	1997	267
Regulation by Thyroid-Stimulating Hormone of Sodium/Iodide Symporter Gene Expression and Protein Levels in FRTL-5 Cells Takahiko Kogai, Toyoshi Endo, Tsukasa Saito, Endocrinology GeneticsNeurotransmitterParathyroid GlandNeurotransmissionMessenger Rna	1997	267
Is Diagnostic Iodine-131 Scanning with Recombinant Human TSH Useful in the Follow-Up of Differentiated Thyroid Cancer after Thyroid Ablation? Ernest L. Mazzaferri, Richard T. Kloos The Journal of Clinical Endocrinology & Metabolism	2002	243
Preparation by Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal Are Comparable for the Detection of Residual Differentiated Thyroid Carcinoma Richard J. Robbins, R. Michael Tuttle, Renu N. Sharaf, The Journal of Clinical Endocrinology & Metabolism Recombinant Human ThyrotropinSurgical OncologyMedicineThyroid DiseasePathology	2001	168
Radioiodine Treatment with 30 mCi after Recombinant Human Thyrotropin Stimulation in Thyroid Cancer: Effectiveness for Postsurgical Remnants Ablation and Possible Role of Iodine Content in<scp>l</scp>-Thyroxine in the Outcome of Ablation Daniele Barbaro, Giuseppe Boni, Giuseppe Meucci, The Journal of Clinical Endocrinology & Metabolism	2003	146
Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice Martin Schlumberger, F Pacini, WM Wiersinga, European Journal of Endocrinology Thyroid CarcinomaLong TermMedicinePapillary Thyroid CarcinomaThyroid Disease	2004	111
Radioiodine Ablation of Thyroid Remnants After Preparation with Recombinant Human Thyrotropin Richard J. Robbins, R. Michael Tuttle, Martin Sonenberg, Thyroid Recombinant Human ThyrotropinMedicineRadionuclide TherapyThyroid DiseaseNormal Thyroid Remnants	2001	110
Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone Gertrud E. B. Berg, G Lindstedt, M Suurküla, Journal of Endocrinological Investigation Radionuclide TherapyThyroid DiseaseRadioiodine AblationDifferentiated Thyroid CancerThyroid Hormone	2002	87

Page 1